Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

被引:35
作者
Moon, Joon Ho [1 ]
Koo, Bo Kyung [1 ,2 ]
Kim, Won [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[3] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Non-alcoholic fatty liver disease; Sarcopenia; Mortality; Nationwide survey; FIBROSIS STAGE; ASSOCIATION; DIAGNOSIS; RISK; MANAGEMENT; AGE; INFLAMMATION; FEATURES; OUTCOMES;
D O I
10.1002/jcsm.12719
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Sarcopenia is an independent risk factor not only for advanced-stage non-alcoholic fatty liver disease (NAFLD) but also for mortality. We investigated the association of sarcopenia and/or NAFLD with mortality among the Korean general population. Methods Individuals aged 35-75 years without any history of cancer, ischaemic heart disease, ischaemic stroke, or secondary causes of chronic liver disease were selected from the Korean National Health and Nutrition Examination Surveys from 2008 to 2015. Their mortality data until December 2018 were retrieved from the National Death Registry. NAFLD and sarcopenia were defined by hepatic steatosis index and appendicular skeletal muscle mass divided by body mass index (BMI), respectively. Results A total of 28 060 subjects were analysed [mean age, 50.6 (standard error, 0.1) years, 48.2 (0.3) % men]; the median follow-up duration was of 6.8 (interquartile range, 4.8, 8.4) years. NAFLD predicted mortality after adjustment for age, sex, BMI, hypertension, dyslipidaemia, and smoking (HR 1.32, 95% CI 1.03-1.70), but this prediction lost its statistical significance after additional adjustment for diabetes mellitus. In contrast, NAFLD with advanced fibrosis independently increased the risk of mortality after adjustment for all covariates (HR 1.68, 95% CI 1.02-2.79). Stratified analysis revealed that NAFLD and sarcopenia additively increased the risk of mortality as an ordinal scale (HR 1.46, 95% CI 1.18-1.81, P for trend = 0.001). The coexistence of NAFLD and sarcopenia increased the risk of mortality by almost twice as much, even after adjustment for advanced fibrosis (HR 2.18, 95% CI 1.38-3.44). Conclusions Concurrent NAFLD and sarcopenia conferred a two-fold higher risk of mortality. The observation that NAFLD and sarcopenia additively increase mortality suggests that risk stratification would be helpful in predicting mortality among those with metabolic derangement.
引用
收藏
页码:964 / 972
页数:9
相关论文
共 50 条
  • [41] Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study
    Cho, A-Ra
    Lee, Jun-Hyuk
    Kwon, Yu-Jin
    LIFE-BASEL, 2021, 11 (08):
  • [42] Effect of resveratrol on non-alcoholic fatty liver disease
    Theodotou, Marios
    Fokianos, Konstantinos
    Moniatis, Demetris
    Kadlenic, Rudolf
    Chrysikou, Asimina
    Aristotelous, Andrea
    Mouzouridou, Alexia
    Diakides, John
    Stavrou, Eliza
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 559 - 565
  • [43] Clinical approaches to non-alcoholic fatty liver disease
    Katherine JP Schwenger
    Johane P Allard
    World Journal of Gastroenterology, 2014, (07) : 1712 - 1723
  • [44] Helicobacter pylori and non-alcoholic fatty liver disease
    Buzas, Gyorgy M.
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (03) : 267 - 279
  • [45] Current treatment of non-alcoholic fatty liver disease
    Paternostro, Rafael
    Trauner, Michael
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (02) : 190 - 204
  • [46] Non-alcoholic fatty liver disease and sleep disorders
    Bu, Lu-Fang
    Xiong, Chong-Yu
    Zhong, Jie-Yi
    Xiong, Yan
    Li, Dong-Ming
    Hong, Fen-Fang
    Yang, Shu-Long
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 304 - 315
  • [47] Coronavirus disease 2019 and non-alcoholic fatty liver disease
    Bellanti, Francesco
    Vendemiale, Gianluigi
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 969 - 978
  • [48] Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease
    Charatcharoenwitthaya, Phunchai
    Karaketklang, Khemajira
    Aekplakorn, Wichai
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (05) : 2393 - 2404
  • [49] Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
    Seo, D. H.
    Lee, Y-H
    Park, S. W.
    Choi, Y. J.
    Huh, B. W.
    Lee, E.
    Huh, K. B.
    Kim, S. H.
    Cha, B-S
    DIABETES & METABOLISM, 2020, 46 (05) : 362 - 369
  • [50] The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men
    Ryoo, Jae-Hong
    Hong, Hyun Pyo
    Park, Sung Keun
    Ham, Woo Taek
    Chung, Ju Youn
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (11) : 1761 - +